Fund shareholders of Assembly Biosciences Inc
ISIN US0453962070 · United States · LEI 5299007Y1X8RBDFT8C40
- Fund shareholders
- 25
- Of which ETFs
- 4 21 other funds
- Value held
- 19.8M $
- Share of capital
- 3.5 % of 20.4M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 347,884 | 9.7M $ | 0.00 % | 1.71 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 130,035 | 3.6M $ | 0.00 % | 0.64 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 59,089 | 1.8M $ | 0.00 % | 0.29 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 23,193 | 643.6K $ | 0.05 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 21,252 | 634.2K $ | 0.00 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Federated Hermes MDT Small Cap Growth Fund Federated Hermes MDT Series | 18,904 | 509.5K $ | 0.07 % | 0.09 % | as of Apr 30, 2026 ↗ |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS | 17,723 | 491.8K $ | 0.02 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 16,917 | 504.8K $ | 0.00 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 9,732 | 290.4K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 7,645 | 206K $ | 0.55 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 6,704 | 180.7K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 6,351 | 176.2K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 6,096 | 181.9K $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 6,073 | 168.5K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 5,773 | 155.6K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 4,966 | 137.8K $ | 0.04 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 4,026 | 108.5K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 3,902 | 105.2K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 3,481 | 96.6K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 1,693 | 45.6K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 1,665 | 46.2K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 1,200 | 32.3K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 1,166 | 34.8K $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 293 | 8.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 58 | 1.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.55 % | as of Apr 30, 2026 ↗ |
| Federated Hermes MDT Small Cap Growth Fund Federated Hermes MDT Series | 0.07 % | as of Apr 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.05 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 0.04 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 0.03 % | as of Feb 28, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 0.01 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 25 | +4 | 705,821 | -0.5 % |
| 2026Q1 | 21 | +2 | 709,358 | +11.0 % |
| 2025Q4 | 19 | 0 | 639,325 | +75.4 % |
| 2025Q3 | 19 | -1 | 364,549 | +10.3 % |
| 2025Q2 | 20 | -4 | 330,450 | +1.2 % |
| 2025Q1 | 24 | +2 | 326,500 | -0.2 % |
| 2024Q4 | 22 | +4 | 327,062 | +4.7 % |
| 2024Q3 | 18 | +2 | 312,265 | +2.1 % |
| 2024Q2 | 16 | 305,751 |
Institutional managers
70 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| GILEAD SCIENCES, INC. | 4,505,391 | 125M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 1,227,590 | 34.1M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 1,020,410 | 28.3M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 1,000,000 | 27.8M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 849,309 | 23.5M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 665,251 | 18.5M $ | as of Mar 31, 2026 |
| Parkman Healthcare Partners LLC | 411,227 | 11.4M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 344,105 | 9.5M $ | as of Mar 31, 2026 |
| Blackstone Inc. | 296,855 | 8.2M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 233,650 | 6.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 202,743 | 5.6M $ | as of Mar 31, 2026 |
| STEMPOINT CAPITAL LP | 185,435 | 5.1M $ | as of Mar 31, 2026 |
| B Group, Inc. | 175,706 | 4.9M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 163,400 | 4.5M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 161,000 | 4.5M $ | as of Mar 31, 2026 |
| Patient Square Capital LP | 136,315 | 3.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 132,971 | 3.7M $ | as of Mar 31, 2026 |
| Schonfeld Strategic Advisors LLC | 120,500 | 3.3M $ | as of Mar 31, 2026 |
| Caption Management, LLC | 81,841 | 2.3M $ | as of Mar 31, 2026 |
| HighVista Strategies LLC | 74,735 | 2.1M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 69,256 | 1.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 56,689 | 1.6M $ | as of Mar 31, 2026 |
| Seven Fleet Capital Management LP | 56,147 | 1.6M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 53,962 | 1.4M $ | as of Mar 31, 2026 |
| MONIMUS CAPITAL MANAGEMENT, LP | 48,390 | 1.3M $ | as of Mar 31, 2026 |
Declared shareholders of Assembly Biosciences Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Paradigm BioCapital Advisors LP and 3 others | 5.40 % | 865,251 | as of May 4, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Assembly Biosciences Inc". https://titelia.com/en/stocks/assembly-biosciences-inc-US0453962070